Skip to main content

Is Venus Remedies a Long-Term Multi-Bagger?

The pharmaceutical sector continues to be an excellent arena for long-term investors seeking robust growth and stable returns. Today, we will take a detailed look at the recent financial indicators and investment recommendations for 'Venus Remedies,' a key player in the pharmaceutical manufacturing industry.

Is Venus Remedies a Long-Term Multi-Bagger?



A Detailed Analysis of the Company's Recent Financial Indicators


If you are considering adding this company's shares to your investment portfolio, here are the key details you need to know, based on market data as of July 14, 2026.

  • Key Overview: Stock Details & Investment Decision
  • Current Share Price: ₹1,895.60 (as of 14.07.2026)
  • Market Capitalization: ₹2,298 Crore
  • Analyst Recommendation: BUY
  • Investment Horizon: 5 Years
  • Target Price: ₹3,380.26
  • Key Highlight: Analysts project significant growth potential of nearly 78% from the current market price, with a target price of ₹3,380.26 over a five-year period.

Key Valuation and Financial Ratios


Understanding key valuation metrics is essential to determine whether the share price is reasonable relative to the company's earnings.

P/E Ratio (Price-to-Earnings Ratio): 22.40 — This indicates a reasonable valuation for a growing pharmaceutical company.

EV/EBITDA: 15.60x — This reflects how the market values ​​the entire business relative to its operating profit. Free Cash Flow (FCF): ₹118 crore — This indicates a healthy cash position, enabling the company to reinvest in Research & Development (R&D) or repay debt.

Estimated EPS (Earnings Per Share) for 2030: ₹107.65 — A forward-looking projection indicating strong earnings per share by the end of the decade.

Factors to Consider


Market presence across 96 countries

Expansion of the distributor network (increased from 4,000 to 10,000)

Diverse product portfolio

Market authorizations for over 1,040 products

Robust financial position. Risks

Continuity of raw material supply

Over 70% of raw materials are imported from China

Strict global quality control standards

Profitability impacted by domestic price controls and global trade competition

Difficulty in sourcing skilled personnel and experts

Stringent environmental regulations posing challenges to success.

Valuation Outlook

Undervalued in the market

The market has yet to fully recognize the company's capabilities and potential

Note: Stock market investments are subject to market risks.

Please read all related documents carefully before investing. SEBI registration and NISM certification do not guarantee a research analyst's performance or investor returns.

Comments

Popular posts from this blog

At one time, the tax rate in India was 97.50

Many feel that foreign countries tax the rich very heavily and India does not. But did you know that at one time India had to pay 97.50 percent of income tax? Indira Gandhi What is the historical tax rate in India Debates such as distribution of wealth and introduction of inheritance tax have arisen and are currently being discussed in a frenzy. But, in our country, 50 years ago, maximum tax was collected up to 97.50 percent. There was such a period in India. During Indira Gandhi's tenure as Prime Minister, income tax in India was as high as 97.50 percent. However, this collection came to an end shortly after. Indira Gandhi saw taxation as an important mechanism to balance income and wealth. Based on this, in February 1970, he presented the budget in Parliament and addressed it. Social welfare was the theme of the budget. Since the green revolution was taking place, various announcements related to the agriculture sector were included in the budget. A huge sum...

Emmvee Photovoltaic Power Share Price Target 2030: Is It a Buy?

The renewable energy sector, particularly the solar energy segment, is growing rapidly. If you are looking for long-term growth opportunities in this sector, 'Emmvee Photovoltaic Power' is a company that warrants your attention. Based on recent market studies and financial reports, we outline the company's key operational metrics here and analyze why market analysts recommend it as an excellent long-term investment. Emmvee Photovoltaic Power: Key Stock and Market Metrics As of July 16, 2026, the company’s stock boasts strong fundamentals, supported by robust operating profit margins and excellent capital utilization. Metric | Details / Statistics Current Share Price (as of 16.07.2026): ₹365.35 Market Capitalization: ₹24,696 Crore Analyst Recommendation: Buy Recommended Investment Horizon: 5 years Expected Target Price (by 2030): ₹628.00 A Detailed Look at Financial and Valuation Ratios To understand why analysts are confident that Emmvee Photovoltaic Power will reach a targ...

What are the weekly employment news updates and notifications?

Learn how weekly employment news updates and notifications help job seekers track new vacancies, industry trends, recruitment announcement, and career growth opportunities. Interested in joining a medical education institute? A notification has been released for vacancies at a postgraduate medical education and research institute operating under the Central Government. There is a total of 60 vacancies, including 54 for MTS, 1 for Medical Officer, 1 for Pharmacist, and 1 for Computer Operator. Educational Qualifications: 10th Standard / D Pharm / MBBS. Age Limit: 18–30 years (as of 19.10.2026). Selection Process: Online examination, skill test, and certificate verification. Application Method: Online. Application Fee: ₹1,500 (₹800 for SC/ST categories). Last Date: 19.10.2026. For details: pgimer.edu.in Engineer Positions at National Power Company A recruitment notification has been released for vacancies at the National Thermal Power Company. There is a total of 17 vacancie...